Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study

Abstract Background This study aimed to evaluate the efficacy and the safety of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing neutropenia in metastatic colorectal cancer (mCRC) patients that received fluorouracil, leucovorin, oxaliplatin, and irinote...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yusuke Kitagawa, Hiroki Osumi, Eiji Shinozaki, Yumiko Ota, Izuma Nakayama, Takeshi Suzuki, Takeru Wakatsuki, Mariko Ogura, Akira Ooki, Daisuke Takahari, Mitsukuni Suenaga, Keisho Chin, Kensei Yamaguchi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2020-04-01
Sarja:BMC Cancer
Aiheet:
FOLFOXIRI plus bevacizumab
Neutropenia
Polyethylene glycol conjugated granulocyte colony-stimulating factor
Linkit:http://link.springer.com/article/10.1186/s12885-020-06864-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia